These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 20555046

  • 1. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ukponmwan CU, Njinaka I, Ehimiyen ET.
    Trop Doct; 2010 Jul; 40(3):167-8. PubMed ID: 20555046
    [Abstract] [Full Text] [Related]

  • 2. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
    Ugburo AO, Temiye EO, Ilombu CA.
    Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M.
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [Abstract] [Full Text] [Related]

  • 4. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D, From L, Ricciatti D, Shapero H.
    Can Med Assoc J; 1978 Jan 21; 118(2):154-6. PubMed ID: 757383
    [Abstract] [Full Text] [Related]

  • 5. The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis.
    Sotozono C, Ueta M, Kinoshita S.
    Arch Dermatol; 2009 Nov 21; 145(11):1336-7; author reply 1337-8. PubMed ID: 19917974
    [No Abstract] [Full Text] [Related]

  • 6. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
    Di Pascuale MA, Espana EM, Liu DT, Kawakita T, Li W, Gao YY, Baradaran-Rafii A, Elizondo A, Raju VK, Tseng SC.
    Ophthalmology; 2005 May 21; 112(5):904-12. PubMed ID: 15878074
    [Abstract] [Full Text] [Related]

  • 7. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E, Köse O, Erbil AH, Nişanci M, Akar A, Gür AR.
    Pediatr Dermatol; 2005 May 21; 22(4):317-20. PubMed ID: 16060867
    [Abstract] [Full Text] [Related]

  • 8. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH.
    Am J Ophthalmol; 2010 Oct 21; 150(4):505-510.e1. PubMed ID: 20619392
    [Abstract] [Full Text] [Related]

  • 9. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb 21; 18(99):20-2. PubMed ID: 19391288
    [Abstract] [Full Text] [Related]

  • 10. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM.
    Cornea; 2007 Feb 21; 26(2):123-9. PubMed ID: 17251797
    [Abstract] [Full Text] [Related]

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
    Mistry RD, Schwab SH, Treat JR.
    Pediatr Emerg Care; 2009 Aug 21; 25(8):519-22. PubMed ID: 19687711
    [Abstract] [Full Text] [Related]

  • 12. Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care centre in south India.
    Kompella VB, Sangwan VS, Bansal AK, Garg P, Aasuri MK, Rao GN.
    Indian J Ophthalmol; 2002 Dec 21; 50(4):283-6. PubMed ID: 12532492
    [Abstract] [Full Text] [Related]

  • 13. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
    Kelly JP, Kaufman DW, Dunant A, Mockenhaupt M, Roujeau JC.
    J Am Acad Dermatol; 2011 Jun 21; 64(6):1193-4. PubMed ID: 21571188
    [No Abstract] [Full Text] [Related]

  • 14. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Wilkins J, Morrison L, White CR.
    Dermatol Clin; 1992 Jul 21; 10(3):571-82. PubMed ID: 1617814
    [Abstract] [Full Text] [Related]

  • 15. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.
    Pediatrics; 2009 Feb 21; 123(2):e297-304. PubMed ID: 19153164
    [Abstract] [Full Text] [Related]

  • 16. [Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases].
    Valeyrie-Allanore L, Ingen-Housz-Oro S, Colin A, Thuillot D, Sigal ML, Binhas M.
    Ann Dermatol Venereol; 2011 Oct 21; 138(10):694-7; quiz 692-3, 698. PubMed ID: 21978510
    [No Abstract] [Full Text] [Related]

  • 17. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB.
    Ned Tijdschr Geneeskd; 1996 Jul 27; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS.
    Ophthalmology; 1995 Nov 27; 102(11):1669-76. PubMed ID: 9098260
    [Abstract] [Full Text] [Related]

  • 19. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA, Goldstein DM.
    Hillside J Clin Psychiatry; 1985 Nov 27; 7(2):141-8. PubMed ID: 4077031
    [Abstract] [Full Text] [Related]

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS.
    Ann Allergy Asthma Immunol; 2005 Apr 27; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.